Mettler-Toledo International, Inc. (NYSE:MTD) Receives $1,282.64 Consensus Target Price from Analysts

Shares of Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) have been assigned an average recommendation of "Hold" from the eleven brokerages that are covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $1,280.90.

A number of brokerages have commented on MTD. Bank of America lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Barclays initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price on the stock. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Wall Street Zen downgraded Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a report on Monday, April 7th.

Mettler-Toledo International Stock Up 1.7%

MTD traded up $20.47 during trading on Wednesday, hitting $1,239.12. The company's stock had a trading volume of 157,879 shares, compared to its average volume of 150,355. The business's 50 day simple moving average is $1,159.21 and its 200-day simple moving average is $1,195.76. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,546.93. The firm has a market cap of $25.75 billion, a PE ratio of 30.90, a P/E/G ratio of 3.75 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The company had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. During the same period in the previous year, the firm earned $8.89 EPS. The firm's revenue was down 4.6% compared to the same quarter last year. Equities research analysts expect that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the completion of the sale, the director directly owned 120 shares in the company, valued at approximately $139,191.60. The trade was a 89.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.94% of the company's stock.

Institutional Investors Weigh In On Mettler-Toledo International

Large investors have recently modified their holdings of the business. Vanguard Group Inc. lifted its position in Mettler-Toledo International by 1.2% during the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock worth $3,003,485,000 after buying an additional 30,535 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after purchasing an additional 126,147 shares during the period. Geode Capital Management LLC grew its stake in shares of Mettler-Toledo International by 2.0% in the fourth quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after buying an additional 11,032 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock valued at $568,032,000 after purchasing an additional 25,272 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its stake in shares of Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after acquiring an additional 43,082 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.